NATIONWIDE — The distributor of a variety of losartan, a popular blood pressure medication, has expanded the drug's recall over concerns it contains more than the acceptable trace amount of a ...

Macleods Pharmaceuticals Limited recalled 32 lots of blood pressure medication losartan after discovering trace amounts of a carcinogen.

It looks that there will be fewer food products recalled in 2024 than 2023, but a national outbreak of listeria stands out among the top 10.

As part of a growing number of blood pressure drug recalls, Torrent Pharmaceuticals has expanded its recall of losartan medication over concerns it contains a carcinogen. Torrent said six ...

FDA announced expanded recall of widely-used blood pressure drug losartan potassium tablets to include an additional five lots.

The recall was expanded on June 11, 2019 to include six additional lots of bulk losartan potassium tablets, particularly two lots of 50 mg and four lots of 100 mg.

The maker of Losartan has widened a recall of the generic blood pressure medicine for the fifth time, according to the U.S. Food and Drug Administration, which warned that some pills may be ...

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient.

A recall for blood pressure drugs has been expanded. Torrent Pharmaceuticals says two of its blood pressure medications were found to have trace amounts of a potentially cancer-causing impurity.

FDA expands blood pressure drug recall, again The voluntary recall involves an additional five lots of the generic drug losartan made by Torrent Pharmaceuticals.

Sandoz announced a voluntary recall of certain lots of Losartan Potassium and Ezetimibe prescription bottles due to not meeting federal standards for child-resistant packaging as required by the ...

Teva Pharmaceuticals has recalled an additional six lots of bulk losartan potassium tablets, expanding a nationwide recall originally initiated in April, the FDA announced June 11.